About
ApiFix is a subsidiary of OrthoPediatrics Corp, dedicated to pediatric orthopedics with a focus on treating adolescent idiopathic scoliosis (AIS). Founded in 2011 and based in Israel and Boston, Massachusetts, ApiFix develops innovative technologies aimed at providing less invasive alternatives to traditional scoliosis treatments. The company's primary product is the ApiFix® Minimally Invasive Deformity Correction (MID-C) system. This system is designed to be implanted using a unilateral posterior approach and features a patented self-adjusting rod mechanism that preserves spinal motion. The ApiFix system is removable and aims to reduce surgery time, blood loss, and recovery time compared to spinal fusion procedures. Since 2012, over 800 AIS patients have benefited from the ApiFix procedure, showcasing its effectiveness. ApiFix targets young patients with AIS who have not found success with bracing and are looking for alternatives to spinal fusion. The company is led by experienced executives and holds a robust intellectual property portfolio, positioning it as a leader in pediatric orthopedic innovation.
Technologies
Keywords
Company Information
-
Employees 10
-
Founded 2011
-
Annual Revenue $3600000
-
Total Funding $5000000
Location
Warsaw, Indiana, United States, 46582